Progyny Files 8-K for Financial Results and Operations Update

TL;DR

Progyny just filed an 8-K reporting financial results, details to follow.

AI Summary

Progyny, Inc. filed an 8-K current report on February 27, 2024, to disclose information regarding its Results of Operations and Financial Condition, along with Financial Statements and Exhibits. This filing, under the Securities Exchange Act of 1934, indicates a routine financial update from the Delaware-incorporated company, whose business address is in New York. The specific financial details and dollar amounts are not provided within this initial filing snippet.

Why It Matters

This 8-K signals that Progyny, Inc. is providing an update on its financial performance and operational status, which is crucial for investors to assess the company's health and future prospects. While specific figures are not included in this snippet, the filing itself is a standard disclosure event.

Risk Assessment

Risk Level: low — This filing is a standard disclosure of financial results and operations, not an announcement of a specific adverse event or significant change, thus the immediate risk is low.

Key Players & Entities

• Progyny, Inc. (company) — Registrant
• United States Securities and Exchange Commission (company) — Regulator
• Delaware (state) — State of Incorporation
• New York (city) — Principal Executive Offices
• Auxogyn, Inc. (company) — Former Company Name

FAQ

Key Financial Figures

• $0.0001 — nge on which registered Common Stock , $0.0001 par value per share PGNY The Nasdaq Gl

Filing Documents

• pgny-20240227.htm (8-K) — 26KB
• exhibit991-annualfy23.htm (EX-99.1) — 380KB
• 0001551306-24-000018.txt ( ) — 559KB
• pgny-20240227.xsd (EX-101.SCH) — 2KB
• pgny-20240227_lab.xml (EX-101.LAB) — 23KB
• pgny-20240227_pre.xml (EX-101.PRE) — 12KB
• pgny-20240227_htm.xml (XML) — 3KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition On February 27, 2024, Progyny, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter and year ended December 31, 2023. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information furnished under this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, regardless of any general incorporation language in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Progyny, Inc. dated February 27, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Progyny, Inc. Dated: February 27, 2024 By: /s/ Peter Anevski Peter Anevski Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR